Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (plus or minus granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma

MLA

Abitbol, Andre A., et al. “Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin, and Mitomycin-C (plus or Minus Granulocyte-Colony Stimulating Factor) in the Treatment of Patients with Locally Advanced Head and Neck Carcinoma.” Cancer, vol. 80, no. 2, July 1997, p. 266. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.19636165&authtype=sso&custid=ns315887.

APA

Abitbol, A. A., Sridhar, K. S., Lewin, A. A., Schwade, J. G., Raub, W., Jr., Wolfson, A., Gonzalez-Angulo, C., Adessa, A., Goodwin, W. J., & Markoe, A. M. (1997, July 15). Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (plus or minus granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma. Cancer, 80(2), 266.

Chicago

Abitbol, Andre A., Kasi S. Sridhar, Alan A. Lewin, James G. Schwade, William Raub Jr., Aaron Wolfson, Carlos Gonzalez-Angulo, Anthony Adessa, W. Jarrard Goodwin, and Arnold M. Markoe. 1997. “Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin, and Mitomycin-C (plus or Minus Granulocyte-Colony Stimulating Factor) in the Treatment of Patients with Locally Advanced Head and Neck Carcinoma.” Cancer, July 15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.19636165&authtype=sso&custid=ns315887.